Comparative Study of Hemostatic Parameters in Type 2 Diabetes Mellitus and Healthy Individuals

dc.contributor.author	Mohammed Kareem Jabbar
dc.date.accessioned	2026-01-02T11:32:25Z
dc.date.issued	2022-09-30
dc.description.abstract	Diabetes mellitus patients with persistent hyperglycemia develop coagulopathies because prothrombin, fibrinogen, and other proteins essential to the clotting process are affected. Reduced prothrombin time (PT) and activated partial thromboplastin time (APTT) show a hypercoagulable condition, which is linked to an elevated thrombotic risk and detrimental cardiovascular outcomes. The coagulation profile of type 2 diabetes mellitus was evaluated in this study. The aim of this study was to determine the blood clotting profiles and risk factors for blood clotting abnormalities in diabetic people
dc.format	application/pdf
dc.identifier.uri	https://geniusjournals.org/index.php/emrp/article/view/2315
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/77376
dc.language.iso	eng
dc.publisher	Genius Journals
dc.relation	https://geniusjournals.org/index.php/emrp/article/view/2315/1994
dc.source	Eurasian Medical Research Periodical; Vol. 12 (2022): EMRP; 88-91
dc.source	2795-7624
dc.subject	Diabetes mellitus,
dc.subject	Hemostatic parameter comparisons
dc.title	Comparative Study of Hemostatic Parameters in Type 2 Diabetes Mellitus and Healthy Individuals
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: jabbar_2022_comparative_study_of_hemostatic_paramete.pdf
item.page.filesection.size: 225.94 KB
item.page.filesection.format: Adobe Portable Document Format